TITANIUM DIOXIDE

Manufacturer
Guerlain
Effective date
2019-12-09
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
legacy-cache
Hydrated at
2026-08-01 23:54:26

Label at a glance#

ProductTENUE DE PERFECTION TIMEPROOF FOUNDATION WITH SUNSCREEN ULTIMATE LASTING PERFECTION BROAD SPECTRUM SPF 20 02 BEIGE CLAIR
Active ingredientTITANIUM DIOXIDE
Label structure11 sections

Indications and uses

Helps prevent sunburn

Dosage and administration

For sunscreen use: Shake well before use. Apply liberally 15 minutes before sun exposure. Reapply at least every two hours. Use a water resistant sunscreen if swimming or sweating. Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measure...

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Titanium Dioxide 2.92 %

Purpose

OTC - PURPOSE SECTION

sunscreen

Uses

INDICATIONS & USAGE SECTION

  • Helps prevent sunburn

Warnings

WARNINGS SECTION

  • For external use only.

• Do not use

OTC - DO NOT USE SECTION

on damaged or broken skin.

• When using this product

OTC - WHEN USING SECTION

  • keep out of eyes. Rinse with water to remove.

• Stop use and ask a doctor

OTC - STOP USE SECTION

if rash occurs.

• Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

  • Shake well before use.
  • Apply liberally 15 minutes before sun exposure.
  • Reapply at least every two hours.
  • Use a water resistant sunscreen if swimming or sweating.
  • Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • Limit time in the sun, especially from 10 a.m.-2 p.m.
  • Wear long-sleeved shirts, pants, hats, and sunglasses.
  • Children under 6 months: Ask a doctor.

Inactive ingredients

INACTIVE INGREDIENT SECTION

AQUA (WATER) - METHYL TRIMETHICONE - DIMETHICONE - ISODODECANE - ALCOHOL - PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE - ACRYLATES/DIMETHICONE COPOLYMER - SILICA - BUTYLENE GLYCOL - MICA - ALUMINUM HYDROXIDE - PHENOXYETHANOL - PHENYL TRIMETHICONE - DISTEARDIMONIUM HECTORITE - SODIUM MYRISTOYL GLUTAMATE - STEARIC ACID -
GLYCERYL UNDECYL DIMETHICONE - VP/VA COPOLYMER - PROPYLENE CARBONATE - PARFUM (FRAGRANCE) - SODIUM CHLORIDE - TROMETHAMINE - BHT - BUTYLPHENYL
METHYLPROPIONAL - LINALOOL - CITRONELLOL - ALPHA-ISOMETHYL IONONE - BENZYL BENZOATE - GERANIOL - [MAY CONTAIN: CI 77891 (TITANIUM DIOXIDE) - CI 77492, CI 77491, CI 77499 (IRON OXIDES)]

Other information

SPL UNCLASSIFIED SECTION

  • Protect this product from excessive heat and direct sun.

Question or comments?

OTC - QUESTIONS SECTION

In USA: 19 East, 57th Street, New York, NY 10022  (07856)

A PERFECT COMPLEXION... EVEN AFTER THE CLOCK STRIKES MIDNIGHT

SPL UNCLASSIFIED SECTION

FOR WOMEN WHO PLACE ALLURE, ELEGANCE AND PERFECTION BEFORE ALL ELSE, GUERLAIN HAS CREATED TENUE DE PERFECTION. NO MERE FOUNDATION, IT IS A MULTISENSORY ELIXIR THAT ADAPTS TO EVERY SITUATION AND ENSURES A PERFECT COMPLEXION THAT REMAINS FLAWLESS EVEN AFTER THE STROKE OF MIDNIGHT.

THREE EPHEMERAL MULTISENSORY OILS FOR DIVINE RESULTS
A FIRST FOR GUERLAIN, THE FORMULA IS BASED ON THREE ESSENTIAL OILS THAT EVAPORATE ONE AFTER THE OTHER, WITH THREE SUCCESSIVE EFFECTS ON THE SKIN: - THE FIRST OIL, THE MOST FLEETING, EVAPORATES UNDER THE FINGERS TO ENSURE PERFECT WEAR FOR THE FOUNDATION, WHICH GENTLY MELTS INTO THE SKIN. - THE SECOND OIL COATS THE SKIN MORE COMPLETELY, ALLOWING THE FOUNDATION TO GLIDE ON AND ENSURING UNIFORM COVERAGE BEFORE VANISHING INTO THE SKIN.
- THE LAST OIL IS THEN RELEASED TO SETTLE AND FIX THE TIMEPROOF COMPLEX LIGHTLY ON THE SKIN ENSURING THAT THE FOUNDATION REMAINS IN PLACE FOR HOURS ON END.

ULTIMATE CORRECTION, ULTIMATE WEAR: THE TIMEPROOF COMPLEX
THE CULMINATION OF GUERLAIN'S EXPERTISE, THIS SOPHISTICATED TECHNOLOGY OF ABSORBENT POWDERS AND CORRECTIVE PIGMENTS SETS TO WORK INSTANTLY, TURNING THE TEXTURE OF THE SKIN VELVETY SOFT AND ENSURING FLAWLESS COVERAGE IN ALL SITUATIONS:

- FOR ULTIMATE CORRECTION, TWO SOFT-FOCUS MICRO-POWDERS PROVIDE COMPLEMENTARY PROPERTIES: THE FIRST, IN THE FORM OF FLECKS, ENVELOPS THE CONTOURS OF THE SKIN TO SMOOTH ITS SURFACE; THE SECOND'S SPHERICAL SHAPE "ROLLS" OVER THE SKIN TO SMOOTH OUT THE APPEARANCE OF FINE LINES AND SOFTEN IMPERFECTIONS.

- FOR IMPECCABLE WEAR, CONCENTRATED PIGMENTS AND ABSORBENT BEADS ARE ENCAPSULATED IN A POLYMER THAT ROLLS ONTO THE SKIN, FORMING A SUPPLE AND UNIFORM VEIL THAT HOLDS FOR HOURS ON END. BEADS OF SILICA FURTHER THE EFFECT BY CAPTURING ANY EXCESS SEBUM, KEEPING THE VEIL INTACT, WHILE THE SPHERICAL MICRO-POWDER HELPS STABLISE THE COLOUR, ENSURING THAT IT DOES NOT CHANGE OR DARKEN.

THE ULTIMATE BEAUTY OF SMOOTH, EVEN-TONED, VELVETY SKIN IS INSTANTLY REVEALED.
INTO THE EVENING AND BEYOND, THE COMPLEXION STAYS IMPECCABLY FRESH AND VIBRANT, AS PERFECT AS WHEN IT WAS FIRST APPLIED.

16-HOUR HOLD REPORTED BY 93% OF WOMEN*
ALL-DAY COMFORT: 90%**
PERFECTLY CORRECTED COMPLEXION: 83%**

* SELF EVALUATION BY 15 WOMEN, AFTER DAILY APPLICATION.
** SATISFACTION TEST INCLUDING 30 WOMEN, IMMEDIATE RESULTS AND AFTER FOUR WEEKS OF DAILY APPLICATION.

© COPYRIGHT GUERLAIN
68, CHAMPS-ELYSEES 75008 PARIS
MADE IN FRANCE
www.guerlain.com  9 M

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

02 BEIGE CLAIR

3 346470 416901

REPIQUAGE USINE

GUERLAIN TENUE DE PERFECTION TIMEPROOF FOUNDATION WITH SUNSCREEN ULTIMATE LASTING PERFECTION BROAD SPECTRUM SPF 20 01 BEIGE PALE 30ml e 1 FL OZ

GUERLAIN TENUE DE PERFECTION TIMEPROOF FOUNDATION WITH SUNSCREEN ULTIMATE LASTING PERFECTION BROAD SPECTRUM SPF 20 02 BEIGE CLAIR

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

l1l1

l2l2l3l3l4l4l5l5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JP5
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP5
.BETA.-CITRONELLOL, (R)-INACTIVE INGREDIENTP01OUT964K5
ALCOHOLINACTIVE INGREDIENT3K9958V90M5
ALUMINUM HYDROXIDEINACTIVE INGREDIENT5QB0T2IUN05
BENZYL BENZOATEINACTIVE INGREDIENTN863NB338G5
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K5
BUTYLPHENYL METHYLPROPIONALINACTIVE INGREDIENTT7540GJV695
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8B5
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O5
DISTEARDIMONIUM HECTORITEINACTIVE INGREDIENTX687XDK09L5
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6755
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRT5
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F3575
GERANIOLINACTIVE INGREDIENTL837108USY5
ISODODECANEINACTIVE INGREDIENTA8289P68Y25
ISOMETHYL-.ALPHA.-IONONEINACTIVE INGREDIENT9XP4LC555B5
LINALOOL, (+/-)-INACTIVE INGREDIENTD81QY6I88E5
METHYL TRIMETHICONEINACTIVE INGREDIENTS73ZQI0GXM5
MICAINACTIVE INGREDIENTV8A1AW08805
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONEINACTIVE INGREDIENTTYP81E471F5
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T5
PHENYL TRIMETHICONEINACTIVE INGREDIENTDR0K5NOJ4R5
PROPYLENE CARBONATEINACTIVE INGREDIENT8D08K3S51E5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU45
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X5
SODIUM MYRISTOYL GLUTAMATEINACTIVE INGREDIENTAYU7QD893W5
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP5
TROMETHAMINEINACTIVE INGREDIENT023C2WHX2V5
WATERINACTIVE INGREDIENT059QF0KO0R5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49817-006849817-0068-1, 49817-0068-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 29 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 6 of 7 · 410 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XPOWDER, FOR SUSPENSION / ORAL98 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRASYNOVIAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION / ORAL1126 mgExact identifier — unii candidate
134 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675SUSPENSION, EXTENDED RELEASE / ORAL2.7 mgExact identifier — unii candidate
21 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL226 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRACAVITARY0.82 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET / SUBLINGUAL0.13 mgExact identifier — unii candidate
32 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
FERROSOFERRIC OXIDEFERROSOFERRIC OXIDEXM0M87F357TABLET, DELAYED RELEASE / ORAL6 mgExact identifier — unii candidate
10 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4PASTE / DENTAL34 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XLIQUID / NASAL7.4 mg/1mlExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRAVESICAL351 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRACARDIAC70 mgExact identifier — unii candidate
134 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTCAPSULE, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
20 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XPOWDER, DENTIFRICE / DENTAL0.03 mg/mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL11 mgExact identifier — unii candidate
134 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BTABLET, CHEWABLE / ORAL5 mgExact identifier — unii candidate
16 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE / ORAL3 mgExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS0.86 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR360 mgExact identifier — unii candidate
134 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, DELAYED RELEASE / ORAL37 mgExact identifier — unii candidate
21 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / SUBLINGUAL10 mgExact identifier — unii candidate
49 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XLIQUID / SUBCUTANEOUS0.7 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM, AUGMENTED / TOPICAL10 mgExact identifier — unii candidate
6 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APLOTION / TOPICAL80 mgExact identifier — unii candidate
26 equally ranked IID candidates
TROMETHAMINETROMETHAMINE023C2WHX2VGEL / TOPICAL56 mgExact identifier — unii candidate
28 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
134 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERROSOFERRIC OXIDEFERROSOFERRIC OXIDEXM0M87F357CAPSULE, DELAYED RELEASE / ORAL6 mgExact identifier — unii candidate
10 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRA-ARTERIAL278 mgExact identifier — unii candidate
134 equally ranked IID candidates
TROMETHAMINETROMETHAMINE023C2WHX2VGEL / TRANSDERMAL10 mgExact identifier — unii candidate
28 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOAP / TOPICAL1.26 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRAMUSCULAR1486 mgExact identifier — unii candidate
134 equally ranked IID candidates
TROMETHAMINETROMETHAMINE023C2WHX2VINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS0.24 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
BENZYL BENZOATEBENZYL BENZOATEN863NB338GINJECTION, SOLUTION / INTRAMUSCULAR750 mgExact identifier — unii candidate
4 equally ranked IID candidates
FERROSOFERRIC OXIDEFERROSOFERRIC OXIDEXM0M87F357CAPSULE, EXTENDED RELEASE / ORAL1.49 mgExact identifier — unii candidate
10 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS0.02 mgExact identifier — unii candidate
32 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, FILM COATED, EXTENDED RELEASE / ORAL3.6 mgExact identifier — unii candidate
21 equally ranked IID candidates
COPOVIDONE K25-31COPOVIDONE K25-31D9C330MD8BFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
16 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / SUBMUCOSAL17 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAVENOUS90 mgExact identifier — unii candidate
134 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL0.15 mgExact identifier — unii candidate
21 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / PARENTERAL584 mgExact identifier — unii candidate
134 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CREAM / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, FILM COATED / ORAL6 mgExact identifier — unii candidate
20 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, FILM COATED, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
26 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XPOWDER, FOR SUSPENSION / ENDOTRACHEAL46.76 mgExact identifier — unii candidate
134 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APPOWDER, FOR SUSPENSION / ORAL1203 mg/5mlExact identifier — unii candidate
26 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SOLUTION / ORAL280 mgExact identifier — unii candidate
49 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii candidate
26 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION / SUBCUTANEOUS0.8 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRABURSAL9 mgExact identifier — unii candidate
134 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTFILM / BUCCAL0.27 mgExact identifier — unii candidate
20 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSPRAY / NASAL30 mgExact identifier — unii candidate
134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ed168bea-e8fa-d93d-e053-2a95a90a7b6d4fdf30c6-059c-4e14-8be4-e2c8e294172d2022-11-09WarningsExact identifier
spl set id: 4fdf30c6-059c-4e14-8be4-e2c8e294172d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.